Just 4 short years ago, Microsoft researchers in India were ideating around a way to monitor patient adherence to TB medications without requiring clinic visits (DOT), which create challenges for patients and an enormous burden for providers. Building on the idea of sending free messages via “missed calls,” an early 99DOTS prototype was born with handwritten numbers on medication blisters.
Fast forward to today…nearly 200,000 patients are being managed via the highly scalable, highly affordable, patient-centered 99DOTS approach. Read about this journey here: https://news.microsoft.com/en-in/features/99dots-tuberculosis-patients/
The Arcady Group is proud to be supporting and coordinating efforts by technology experts, like those at Everwell Health, global health organizations, researchers, and many others to address the cxhallenge of poor treatment adherence and, thus, reduce the burden, transmission, recurrence, and drug resistance often associated with tuberculosis in resource-limited countries.